At our clinic, we recognize that each patient responds differently to GLP-1 treatments
By helping control blood sugar levels, semaglutide can reduce the risk of complications from diabetes, such as heart disease, kidney damage, and nerve damage
People typically lost at least 20% of their body weight after a year of treatment
Procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass typically result in 25-35% total body weight loss, offering a greater likelihood of resolving obesity-related comorbidities like type 2 diabetes, hypertension, and obstructive sleep apnea
For patients tracking their progress on semaglutide , understanding which pen you are using helps you correlate your results with your current dose level